Class information for:
Level 1: MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MYELOID DERIVED SUPPRESSOR CELL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
9065 1124 53.0 95%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
151 22214 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MYELOID DERIVED SUPPRESSOR CELLS Author keyword 168 57% 17% 196
2 MDSC Author keyword 31 34% 7% 76
3 MYELOID DERIVED SUPPRESSOR CELL Author keyword 23 52% 3% 32
4 MYELOID DERIVED SUPPRESSOR CELLS MDSCS Author keyword 19 76% 1% 13
5 MDSCS Author keyword 15 45% 2% 25
6 MYELOID DERIVED SUPPRESSOR CELLS MDSC Author keyword 7 53% 1% 10
7 IMMATURE MYELOID CELLS Author keyword 6 58% 1% 7
8 TUMOR INDUCED IMMUNE SUPPRESSION Author keyword 5 60% 1% 6
9 CITIM 2011 Author keyword 4 67% 0% 4
10 ENDOTHELIAL LIKE DIFFERENTIATION Author keyword 4 75% 0% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 MYELOID DERIVED SUPPRESSOR CELLS 168 57% 17% 196 Search MYELOID+DERIVED+SUPPRESSOR+CELLS Search MYELOID+DERIVED+SUPPRESSOR+CELLS
2 MDSC 31 34% 7% 76 Search MDSC Search MDSC
3 MYELOID DERIVED SUPPRESSOR CELL 23 52% 3% 32 Search MYELOID+DERIVED+SUPPRESSOR+CELL Search MYELOID+DERIVED+SUPPRESSOR+CELL
4 MYELOID DERIVED SUPPRESSOR CELLS MDSCS 19 76% 1% 13 Search MYELOID+DERIVED+SUPPRESSOR+CELLS+MDSCS Search MYELOID+DERIVED+SUPPRESSOR+CELLS+MDSCS
5 MDSCS 15 45% 2% 25 Search MDSCS Search MDSCS
6 MYELOID DERIVED SUPPRESSOR CELLS MDSC 7 53% 1% 10 Search MYELOID+DERIVED+SUPPRESSOR+CELLS+MDSC Search MYELOID+DERIVED+SUPPRESSOR+CELLS+MDSC
7 IMMATURE MYELOID CELLS 6 58% 1% 7 Search IMMATURE+MYELOID+CELLS Search IMMATURE+MYELOID+CELLS
8 TUMOR INDUCED IMMUNE SUPPRESSION 5 60% 1% 6 Search TUMOR+INDUCED+IMMUNE+SUPPRESSION Search TUMOR+INDUCED+IMMUNE+SUPPRESSION
9 CITIM 2011 4 67% 0% 4 Search CITIM+2011 Search CITIM+2011
10 ENDOTHELIAL LIKE DIFFERENTIATION 4 75% 0% 3 Search ENDOTHELIAL+LIKE+DIFFERENTIATION Search ENDOTHELIAL+LIKE+DIFFERENTIATION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ACTIVATED GRANULOCYTES 52 73% 4% 40
2 TUMOR BEARING MICE 35 20% 14% 157
3 IMMUNE SUPPRESSION 29 19% 12% 137
4 SUPPRESSOR CELLS 27 12% 20% 220
5 MYELOID SUPPRESSOR CELLS 26 28% 7% 78
6 BEARING HOST 21 61% 2% 23
7 TUMOR BEARING HOST 19 63% 2% 19
8 ARGINASE I 18 37% 3% 39
9 IMMATURE MYELOID CELLS 14 31% 3% 39
10 CARCINOMA PATIENTS 9 12% 6% 68

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells 2015 6 93 81%
Coordinated regulation of myeloid cells by tumours 2012 501 197 52%
Myeloid-derived suppressor cells as regulators of the immune system 2009 1561 130 65%
Complexity and Challenges in Defining Myeloid-Derived Suppressor Cells 2015 3 121 74%
Myeloid regulatory cells in tumor spreading and metastasis 2015 3 74 59%
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function 2011 148 73 84%
Myeloid derived suppressor cells in human diseases 2011 112 66 91%
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 2009 578 96 66%
Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications 2014 13 67 76%
Myeloid-derived suppressor cell heterogeneity and subset definition 2010 229 42 71%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 INTEGRATED BIOMED SCI 4 75% 0.3% 3
2 MED MICROBIOL TUMOR VIROL CANC IMMUNOTHERA 3 100% 0.3% 3
3 PROVIDENCE HEPATOBILIARY PANCREAT CANC PROGRAM 2 67% 0.2% 2
4 GASTROINTESTINAL MALIGNANCY SECT 2 28% 0.4% 5
5 ONCOL IMMUNOL SECT 2 33% 0.4% 4
6 GI MALIGNANCY SECT 1 50% 0.2% 2
7 PERITONEAL OVARIAN CANC SPECIALTY CARE 1 50% 0.2% 2
8 TWINCORE EXPT CLIN 1 50% 0.2% 2
9 MED HEMATOL ONCOL PNEUMOL 3 1 23% 0.4% 5
10 MICROBIOL IMMUNOL CANC BIOL PROGRAM 1 19% 0.4% 5

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000149569 TUMOR ASSOCIATED MACROPHAGES//TUMOR ASSOCIATED MACROPHAGE//TUMOUR ASSOCIATED MACROPHAGES
2 0.0000147366 FOXP3//TUMOR INFILTRATING LYMPHOCYTES//INTEGRAT CANC IMMUNOL
3 0.0000133189 CD3 ZETA//ORAL BIOL ORAL MED//ZETA CHAIN
4 0.0000108605 CCDC134//TUMOR IMMUN TOLERANCE SECT//ANTIGEN SPECIFIC CTL FUNCTION
5 0.0000087705 IMMUNE SUPPRESSOR CELLS//IRX 2//SERV 151Z2
6 0.0000075926 RECOMBINANT VACCINE GRP//ABSCOPAL EFFECT//IMMUNOGENIC TUMOR CELL DEATH
7 0.0000073511 ARGINASE//NOR NOHA//ARGINASE II
8 0.0000063242 WARD COLON TUMOR//MAIF//MAMMARY TUMOR BEARERS
9 0.0000061732 ANTIANGIOGENIC CANCER VACCINE//CELL PROTEOMIC FOOTPRINTING//HER1 VACCINE
10 0.0000061119 UNITA OPERAT ASSISTENZIALE GINECOL ONCOL//CD1A//CDLA